Free Trial
→ Trump to redistribute trillions of dollars (From Porter & Company) (Ad)

10 Best Small Cap Stocks to Buy Now - 5 of 10

Slide 5
Back to 4
Continue to 6
 
Back to 4
Continue to 6
 

Marker Therapeutics (NASDAQ:MRKR)

Consensus Rating
Strong Buy
Rating Score
3.5
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$13.17 (1,202.3% Upside)

About Marker Therapeutics

Marker Therapeutics logoMarker Therapeutics, Inc, a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. More about Marker Therapeutics
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/1/2025WBB SecuritiesReiterated RatingStrong-Buy ➝ Strong-Buy$12.50 ➝ $12.50
3/5/2025Canaccord Genuity GroupInitiated CoverageBuy$8.00
2/10/2025Brookline Capital ManagementUpgradeStrong-Buy
10/21/2024LADENBURG THALM/SH SHBoost Price TargetBuy ➝ Buy$11.00 ➝ $19.00
4/30/2024LADENBURG THALM/SH SHInitiated CoverageBuy$11.00
5/27/2022Piper SandlerLower Price Target$3.50 ➝ $1.50
Slide 5
Back to 4
Continue to 6
 

More From MarketBeat
Feds Just Admitted It—They Can Take Your Cash
The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...
Priority Gold | Sponsored
7 Sensational Small-Cap Stocks Set for Big Gains
The Russell 2000 Index is up more than 40% in the last 12 months. This is an index that tracks the performance...
MarketBeat
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Betting on a Santa Claus Rally? Consider These 7 Risk-On Stocks
We're getting into the time of year when people start talking about a Santa Claus rally. Specifically, that's ...
MarketBeat
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
The 7 Best Electric Vehicle Stocks That Aren't Tesla
We all know that electric vehicles are the future of day-to-day transportation. They are simpler to manufactur...
MarketBeat